RegPak Launches Herbal Medicine For Cancer Treatment

By Admin
Netherlands company, RegPak Bio-Pharma today announced its collaboration with Taiwan based firm Meriyana International Biotechnology to sell Chinese h...

 

Netherlands company, RegPak Bio-Pharma today announced its collaboration with Taiwan based firm Meriyana International Biotechnology to sell Chinese herbal medicine for cancer treatment in India, through its Indian subsidiary CanCure.

Announcing this, Parminder Kaur, CEO of RegPak BioPharma said, “Doctors have been shortlisted to undergo training in Taiwan to work in the CanCure Clinics to be set up in Chandigarh and later, various parts of Punjab.”

She said a substantial number of patients suffer from cancer in various areas of Punjab and claimed that the Chinese medicine would be helpful in treating those patients effectively.

Accompanied by the representatives of Meriyana International, Parminder Kaur said the herbal medicine, ‘Chinmanna’, has undergone several clinical trials in Taiwan, and that RegPak would be introducing it very soon in Europe where it has got the approvals to be introduced as compassionate medicine for terminal cancer patients.

Chinmanna is launched for treatment of various types of cancers including breast, stomach, throat, mouth, pancreas, intestinal and spleen cancer, she said.

Share

Featured Articles

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Joanna Smith, Digital Advisory Lead at consulting company Lexica, explores the impact of COVID-19 on digital healthcare & what role health data can play

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma

AutoRABIT CEO Meredith Bell on DevOps strategy in healthcare

Hospitals